Elite Pharmaceuticals, Inc. (ELTP)

USD 0.55

(-0.36%)

Annual Balance Sheets

(In USD)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 83.65 Million 40.89 Million 35.14 Million 26.18 Million 24.95 Million 24.4 Million
Total Current Assets 40.01 Million 21.51 Million 18.86 Million 12.19 Million 10.25 Million 8.85 Million
Cash And Short Term Investments 7.1 Million 7.83 Million 8.53 Million 3.19 Million 1.13 Million 2.27 Million
Cash and Cash Equivalents 7.1 Million 7.83 Million 8.53 Million 3.19 Million 1.13 Million 2.27 Million
Short Term Investments - - - - - -
Net Receivables 19.45 Million 3.09 Million 3.05 Million 3.49 Million 4.1 Million 1.32 Million
Inventory 12.93 Million 9.55 Million 6.74 Million 5.01 Million 4.14 Million 4.51 Million
Other Current Assets 524.16 Thousand 1.03 Million 526.94 Thousand 492.62 Thousand 870.23 Thousand 741.37 Thousand
Total Non-Current Assets 43.63 Million 19.38 Million 16.28 Million 13.99 Million 14.7 Million 15.54 Million
Net PPE 14.61 Million 10.43 Million 6.98 Million 6.86 Million 7.59 Million 8.44 Million
Good Will And Intangible Assets 6.34 Million 6.34 Million 6.63 Million 6.63 Million 6.63 Million 6.63 Million
Good Will - - - - - -
Intangible Assets 6.34 Million 6.34 Million 6.63 Million 6.63 Million 6.63 Million 6.63 Million
Long-Term Investments 432.83 Thousand 21.01 Thousand 405.03 Thousand 405.01 Thousand 404.8 Thousand 398.12 Thousand
Tax Assets 22.16 Million 2.17 Million 2.17 Million -405.01 Thousand -404.8 Thousand -398.12 Thousand
Other Non Current Assets 94.24 Thousand 412.43 Thousand 91.73 Thousand 496.75 Thousand 480.33 Thousand 467.5 Thousand
Other Assets - - - - - -
Total Liabilities 26.07 Million 11.93 Million 9.92 Million 10.03 Million 14.3 Million 13 Million
Total Current Liabilities 13.04 Million 7.83 Million 6.69 Million 5.81 Million 8.63 Million 6.9 Million
Account Payables 2.71 Million 2.44 Million 1.43 Million 929.69 Thousand 1.57 Million 1.37 Million
Tax Payables 485.32 Thousand 414.98 Thousand 414.98 Thousand - - -
Short Term Debt 5.02 Million 325.76 Thousand 556.78 Thousand 598.9 Thousand 2.06 Million 653.85 Thousand
Deferred Revenue 13.33 Thousand 13.33 Thousand 13.33 Thousand 13.33 Thousand 180 Thousand 1.16 Million
Other Current Liabilities 5.3 Million 5.04 Million 4.69 Million 4.27 Million 4.82 Million 3.71 Million
Total Non Current Liabilities 13.02 Million 4.1 Million 3.23 Million 4.22 Million 5.66 Million 6.09 Million
Long-Term Debt 3.27 Million 3.56 Million 2.22 Million 1.77 Million 1.96 Million 3.32 Million
Deferred Revenue Non Current 5556.00 18.89 Thousand 32.22 Thousand 45.55 Thousand 58.89 Thousand 238.89 Thousand
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 6.29 Million 4.08 Billion 975.61 Thousand 37.62 Thousand 35.44 Thousand 46.4 Thousand
Other Liabilities - - - - - -
Total Equity 57.58 Million 28.96 Million 25.22 Million 16.15 Million 10.65 Million 11.39 Million
Stock Holders Equity 57.58 Million 28.96 Million 25.22 Million 16.15 Million 10.65 Million 11.39 Million
Common Stock 1.06 Million 1.01 Million 1.01 Million 1 Million 840.5 Thousand 824.94 Thousand
Retained Earnings -116.38 Million -136.49 Million -140.05 Million -148.95 Million -154.04 Million -151.8 Million
Accumulated other comprehensive income - - - - - -9.65 Million
Common Stock Equity 57.58 Million 28.96 Million 25.22 Million 16.15 Million 10.65 Million 11.39 Million
Capital Lease Obligation 3.43 Million 14.91 Thousand 1.03 Million 226.95 Thousand 375.29 Thousand -
Total Investments 432.83 Thousand 21.01 Thousand 405.03 Thousand 405.01 Thousand 404.8 Thousand 398.12 Thousand
Total Debt 11.73 Million 3.88 Million 2.78 Million 2.37 Million 4.02 Million 3.98 Million
Net Debt 4.63 Million -3.94 Million -5.75 Million -814.26 Thousand 2.89 Million 1.7 Million

Balance Sheet Charts